138 results on '"Ioannides, Constantin G"'
Search Results
2. Supplementary Figures 1-3, Tables 1-3 from Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells
3. Supplementary Tables 1-5, Figure Legends 1-3 from Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
4. Supplementary Figures 1-3 from Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
5. Data from Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
6. Supplementary Methods from Fine Specificity of High Molecular Weight-Melanoma-Associated Antigen-Specific Cytotoxic T Lymphocytes Elicited by Anti-Idiotypic Monoclonal Antibodies in Patients with Melanoma
7. Supplementary Figure 1 from BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells
8. Identification of a Second T-Cell Antigen Receptor in Human and Mouse by an Anti-Peptide γ -Chain-Specific Monoclonal Antibody
9. A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403–455)
10. Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
11. Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients
12. Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity
13. Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides
14. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
15. HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells
16. Synthetic microRNA Targeting Glioma-associated Antigen-1 Protein
17. Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides
18. Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation
19. Working Hypothesis: Elimination of Cancer Stem Cells in Solid Tumors by Immuno-Gene Therapy Using Cancer Vaccines and Created-Inhibitory RNA
20. Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients
21. Induction of interleukin-2 receptor by tumor necrosis factor α on cultured ovarian tumor-associated lymphocytes
22. Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2: Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients
23. Changes in an HER-2 Peptide Upregulating HLA-A2 Expression Affect Both Conformational Epitopes and CTL Recognition: Implications for Optimization of Antigen Presentation and Tumor-Specific CTL Induction
24. Novel immunologic strategies in ovarian carcinoma
25. Tumor Immunity by Hydrophobic Bearing Antigens
26. Tumor Immunity by Hydrophobic Appendage Bearing Antigens
27. Epitope Specific T Cell Immunity to Breast Cancer
28. Characterization of CTL Recognized Epitopes on Human Breast Tumors
29. Characterization of CTL Recognized Epitopes on Human Breast Tumors
30. Epitope Specific T-Cell Immunity to Breast Cancer
31. A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403–455)
32. Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
33. New epitopes to improve peptide vaccination against the tumor‐associated antigen Survivin
34. Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
35. Taxol Increases the Amount and T Cell–Activating Ability of Self-Immune Stimulatory Multimolecular Complexes Found in Ovarian Cancer Cells
36. Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells
37. Prostate Tumor Cells Infected with a Recombinant Influenza Virus Expressing a Truncated NS1 Protein Activate Cytolytic CD8 + Cells To Recognize Noninfected Tumor Cells
38. HER-2-Nascent Polypeptide Chain Bound on Ribosomes Translating Influenza Virus Proteins Induces Differentiation of CD8+ Cells
39. Antigenic Regions Containing Both T-Helper and T-Regulatory Overlapping Epitopes in the HER2/neu Molecule
40. Functional Idiotopes: Tumor Antigen–Directed Expression of CD8+ T-Cell Epitopes Nested in Unique NH2-terminal VH Sequence of Antiidiotypic Antibodies?
41. Sensitivity of Undifferentiated, High-TCR Density CD8+ Cells to Methylene Groups Appended to Tumor Antigen Determines Their Differentiation or Death
42. BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells
43. Fine Specificity of High Molecular Weight-Melanoma-Associated Antigen-Specific Cytotoxic T Lymphocytes Elicited by Anti-Idiotypic Monoclonal Antibodies in Patients with Melanoma
44. Activation of Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTLs) by Human Dendritic Cells Infected with an Attenuated Influenza A Virus Expressing a CTL Epitope Derived from the HER-2/neu Proto-Oncogene
45. Synthetic microRNA Targeting Glioma-associated Antigen-1 Protein.
46. Induction of Tumor-Reactive CTL by C-Side Chain Variants of the CTL Epitope HER-2/neu Protooncogene (369-377) Selected by Molecular Modeling of the Peptide: HLA-A2 Complex
47. Axillary Lymph Node Cellular Immune Response to HER-2/neu Peptides in Patients with Carcinoma of the Breast
48. The Comparison of Cytotoxic T-Lymphocyte Effects of Dendritic Cells Stimulated by the Folate Binding Protein Peptide Cultured with IL-15 and IL-2 in Solid Tumor
49. Lymphocytes from ovarian and breast cancer patients secrete the anti-angiogenic CXC chemokine IP-10 in response to tumor antigens
50. Oxidant-Induced S-Glutathiolation Inactivates Protein Kinase C-α (PKC-α): A Potential Mechanism of PKC Isozyme Regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.